Literature DB >> 31383683

Metastatic uterine leiomyosarcoma at 26 weeks gestation.

Naomi Eastwood-Wilshere1, Jessica Turner2, Niara Oliveira3, Adam Morton4,5.   

Abstract

Uterine leiomyosarcoma (ULMS) is a highly malignant neoplasm which has been rarely described in pregnancy. A case of advanced metastatic ULMS presenting at 26 weeks gestation is reported. The principles in managing invasive cancer in pregnancy are discussed. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  chemotherapy; oncology; pregnancy; radiology

Mesh：

Year:  2019        PMID： 31383683      PMCID： PMC6685384          DOI： 10.1136/bcr-2019-230028

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  11 in total

Review 1.  Uterine myxoid leiomyosarcoma with an underlying haematological disorder--case report and review of literature.

Authors:  Joanne Ritchie; Usha Kumari
Journal:  BMJ Case Rep       Date:  2011-12-20

2.  Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.

Authors:  Soshi Kusunoki; Yasuhisa Terao; Takafumi Ujihira; Kazunari Fujino; Hiroshi Kaneda; Miki Kimura; Tsuyoshi Ota; Satoru Takeda
Journal:  Taiwan J Obstet Gynecol       Date:  2017-08       Impact factor: 1.705

Review 3.  Uterine malignant leiomyoblastoma (epithelioid leiomyosarcoma) during pregnancy.

Authors:  R L Bekkers; L F Massuger; P P Berg; U G Haelst; J Bulten
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

4.  Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls.

Authors:  Elyce H Cardonick; Marcy B Gringlas; Krystal Hunter; Jay Greenspan
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

5.  Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients.

Authors:  Jorine de Haan; Magali Verheecke; Kristel Van Calsteren; Ben Van Calster; Roman G Shmakov; Mina Mhallem Gziri; Michael J Halaska; Robert Fruscio; Christianne A R Lok; Ingrid A Boere; Paolo Zola; Petronella B Ottevanger; Christianne J M de Groot; Fedro A Peccatori; Karina Dahl Steffensen; Elyce H Cardonick; Evgeniya Polushkina; Lukas Rob; Lorenzo Ceppi; Gennady T Sukhikh; Sileny N Han; Frédéric Amant
Journal:  Lancet Oncol       Date:  2018-01-26       Impact factor: 41.316

Review 6.  Pregnancy outcome following non-obstetric surgical intervention.

Authors:  Raanan Cohen-Kerem; Craig Railton; Dana Oren; Michael Lishner; Gideon Koren
Journal:  Am J Surg       Date:  2005-09       Impact factor: 2.565

Review 7.  Pregnancy and genital sarcoma: a systematic review of the literature.

Authors:  Koji Matsuo; Michele L Eno; Dwight D Im; Neil B Rosenshein
Journal:  Am J Perinatol       Date:  2009-03-13       Impact factor: 1.862

8.  Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy.

Authors:  Frédéric Amant; Tineke Vandenbroucke; Magali Verheecke; Monica Fumagalli; Michael J Halaska; Ingrid Boere; Sileny Han; Mina Mhallem Gziri; Fedro Peccatori; Lukas Rob; Christianne Lok; Petronella Witteveen; Jens-Uwe Voigt; Gunnar Naulaers; Lore Vallaeys; Frank Van den Heuvel; Lieven Lagae; Luc Mertens; Laurence Claes; Kristel Van Calsteren
Journal:  N Engl J Med       Date:  2015-09-28       Impact factor: 91.245

Review 9.  Effects of cancer treatment during pregnancy on fetal and child development.

Authors:  Tineke Vandenbroucke; Magali Verheecke; Monica Fumagalli; Christianne Lok; Frédéric Amant
Journal:  Lancet Child Adolesc Health       Date:  2017-09-29

Review 10.  Conflicting priorities in surgical intervention for cancer in pregnancy.

Authors:  Brendan J Moran; Hideaki Yano; Niall Al Zahir; Margaret Farquharson
Journal:  Lancet Oncol       Date:  2007-06       Impact factor: 41.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.